Harry Novotny

Harry Novotny has a diverse and extensive work experience spanning over two decades. Harry currently holds the position of National Account Director at Avadel Pharmaceuticals plc, starting in November 2022.

Prior to that, Harry served in various roles at Greenwich Biosciences from 2017 to 2022. Harry was the Director of Long Term Care from 2019 to 2022, where they played a key role in developing pricing strategies and value propositions for the launch of Epidiolex in the US market. From 2017 to 2019, they worked as a Payer Account Director, responsible for building a strong Market Access team and infrastructure within the company.

Before joining Greenwich Biosciences, Harry worked at Avanir Pharmaceuticals as a Senior National Account Executive in Managed Markets from 2014 to 2017. Harry also had a role as a National Account Manager in Managed Markets at Impax Laboratories from 2012 to 2014.

Harry's career also includes experience as a Regional Sales Manager at Marine Polymer Technologies in 2012 and as a National Account Manager in Managed Markets at Par Specialty Pharmaceuticals from 2006 to 2012. During their tenure at Par Specialty Pharmaceuticals, they covered various Managed Care Accounts and LTC accounts, demonstrating their expertise in managing these markets.

Early in their career, Harry held positions at The Janssen Pharmaceutical Companies of Johnson & Johnson. Harry worked as a District Manager from 2002 to 2006, as a Specialty Sales Representative in Long-Term Care from 1999 to 2002, and as a Sales Representative from 1997 to 1999.

Overall, Harry Novotny has a strong background in pharmaceuticals, with significant experience in national accounts, managed markets, and market access. Harry'sexpertise in these areas makes him a valuable asset to the companies they have worked for.

Harry Novotny attended the University of Richmond from 1991 to 1995. However, no information is provided regarding their degree or field of study during their time at the university. From 1995 to 1997, they furthered their education at the Crummer Graduate School of Business at Rollins College, earning an MBA with a focus on Marketing/Finance.